Report cover image

Gene Therapy Market

Publisher Evolve Business Intelligence
Published Apr 14, 2025
SKU # EVBI19932053

Description

The Gene Therapy Market is projected to reach USD 29.74 billion by 2033, growing from USD 8.64 billion in 2023 at a robust compound annual growth rate (CAGR) of 19.1% over the period. Gene therapy represents an advanced medical strategy designed to treat or prevent genetic disorders, diseases, or acquired conditions by introducing, modifying, or replacing genetic material within an individual's cells. This innovative approach aims to correct defective genes by delivering therapeutic genes directly to targeted tissues or utilizing modified viruses as carriers. By tackling the underlying genetic causes at the molecular level, gene therapy offers the potential to cure conditions previously deemed incurable. However, as an evolving field, it requires thorough evaluation, ethical considerations, and careful long-term monitoring to ensure its safety and effectiveness for widespread use.

The latest research report by Evolve Business Intelligence explores the various factors influencing the global market. It includes an analysis of the current market size, forecasts for key segments and regions, and the driving forces behind market growth. The report examines the potential impacts of key trends on business strategies and provides a SWOT analysis of critical sectors for each major competitor and customer group. This valuable data highlights the conglomerates likely to impact the industry, crucial for any company planning to invest strategically over the next five years. These insights complement our initial quantitative study, aiding in new investments and strategic planning to mitigate threats in existing sectors.

Segments covered

By Therapy Type (Somatic, Germline)
By Vector Type (Non-Viral Vectors, Viral Vectors)
By Application (Cancer Diseases, Monogenic Diseases, Infectious Diseases, Cardiovascular Diseases, Others)

Key players

REGENXBIO Inc
Oxford BioMedica plc
Dimension Therapeutics Inc
Bristol-Myers Squibb Company
SANOFI
Applied Genetic Technologies Corporation
Hoffmann-La Roche Ltd
bluebird Bio Inc
Novartis AG
Taxus Cardium Pharmaceuticals Group Inc

Table of Contents

CHAPTER 1. Executive Summary
CHAPTER 2. Scope of the Study
2.1. Market Definition
2.2. Market Scope & Segmentation
2.2.1. Objective of Report
CHAPTER 3. Evolve BI Methodology
3.1. Data Collection & Validation Approach
3.2. Market Size Estimation and Forecast
CHAPTER 4. Exclusive Analysis
4.1. Market Opportunity Score
4.1.1. Therapy Type Segement – Market Opportunity Score
4.1.2. Vector Type Segment – Market Opportunity Score
4.1.3. Application Segment – Market Opportunity Score
4.2. Key Market Influencing Indicators
CHAPTER 5. Market Insights and Trends
5.1. Value Chain Analysis
5.1.1. Raw Material
5.1.2. Manufacturing Process
5.1.3. Distribution Channel
5.1.4. End User
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Buyers
5.2.2. Bargaining Power of Suppliers
5.2.3. Threat of New Entrant
5.2.4. Threat of Substitute
5.2.5. Industry Rivalry
5.3. COVID-19 Impact and Post COVID Scenario on Gene Therapy Market
5.3.1. Impact of COVID-19
5.3.2. Government Support and Industry Revival Policies
5.3.3. Measures Taken by Companies to Mitigate Negative Impact
5.3.4. Post COVID Trend
CHAPTER 6. MArket Dynamics
6.1. Introduction
6.2. Drivers
6.2.1. Driver 1
6.2.2. Driver 2
6.2.3. Driver 3
6.3. Restraints
6.3.1. Restraint 1
6.3.2. Restraint 2
6.4. Opportunity
6.4.1. Opportunity 1
CHAPTER 7. Global Gene Therapy Market, By Therapy Type
7.1. Introduction
7.1.1. Somatic
7.1.2. Germline
CHAPTER 8. Global Gene Therapy Market, By Vector Type
8.1. Introduction
8.1.1. Non-Viral Vectors
8.1.2. Viral Vectors
CHAPTER 9. Global Gene Therapy Market, By Application
9.1. Introduction
9.1.1. Cancer Diseases
9.1.2. Monogenic Diseases
9.1.3. Infectious Diseases
9.1.4. Cardiovascular Diseases
9.1.5. Others
CHAPTER 10. Global Gene Therapy Market, By Region
10.1. Introduction
10.2. NORTH AMERICA
10.2.1. North America: Market Size and Forecast, By Country, 2023 – 2033 ($ Million)
10.2.2. North America: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million)
10.2.3. North America: Market Size and Forecast, By Vector Type, 2023 – 2033 ($ Million)
10.2.4. North America: Market Size and Forecast, By Application, 2023 – 2033 ($ Million)
10.2.5. US
10.2.5.1. US: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million)
10.2.5.2. US: Market Size and Forecast, By Vector Type, 2023 – 2033 ($ Million)
10.2.5.3. US: Market Size and Forecast, By Application, 2023 – 2033 ($ Million)
10.2.6. CANADA
10.2.6.1. Canada: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million)
10.2.6.2. Canada: Market Size and Forecast, By Vector Type, 2023 – 2033 ($ Million)
10.2.6.3. Canada: Market Size and Forecast, By Application, 2023 – 2033 ($ Million)
10.2.7. MEXICO
10.2.7.1. Mexico: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million)
10.2.7.2. Mexico: Market Size and Forecast, By Vector Type, 2023 – 2033 ($ Million)
10.2.7.3. Mexico: Market Size and Forecast, By Application, 2023 – 2033 ($ Million)
10.3. Europe
10.3.1. Europe: Market Size and Forecast, By Country, 2023 – 2033 ($ Million)
10.3.2. Europe: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million)
10.3.3. Europe: Market Size and Forecast, By Vector Type, 2023 – 2033 ($ Million)
10.3.4. Europe: Market Size and Forecast, By Application, 2023 – 2033 ($ Million)
10.3.5. U.K.
10.3.5.1. U.K.: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million)
10.3.5.2. U.K.: Market Size and Forecast, By Vector Type, 2023 – 2033 ($ Million)
10.3.5.3. U.K.: Market Size and Forecast, By Application, 2023 – 2033 ($ Million)
10.3.6. GERMANY
10.3.6.1. Germany: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million)
10.3.6.2. Germany: Market Size and Forecast, By Vector Type, 2023 – 2033 ($ Million)
10.3.6.3. Germany: Market Size and Forecast, By Application, 2023 – 2033 ($ Million)
10.3.7. FRANCE
10.3.7.1. France: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million)
10.3.7.2. France: Market Size and Forecast, By Vector Type, 2023 – 2033 ($ Million)
10.3.7.3. France: Market Size and Forecast, By Application, 2023 – 2033 ($ Million)
10.3.8. ITALY
10.3.8.1. Italy: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million)
10.3.8.2. Italy: Market Size and Forecast, By Vector Type, 2023 – 2033 ($ Million)
10.3.8.3. Italy: Market Size and Forecast, By Application, 2023 – 2033 ($ Million)
10.3.9. SPAIN
10.3.9.1. Spain: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million)
10.3.9.2. Spain: Market Size and Forecast, By Vector Type, 2023 – 2033 ($ Million)
10.3.9.3. Spain: Market Size and Forecast, By Application, 2023 – 2033 ($ Million)
10.3.10. BENELUX
10.3.10.1. BeNeLux: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million)
10.3.10.2. BeNeLux: Market Size and Forecast, By Vector Type, 2023 – 2033 ($ Million)
10.3.10.3. BeNeLux: Market Size and Forecast, By Application, 2023 – 2033 ($ Million)
10.3.11. RUSSIA
10.3.11.1. Russia: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million)
10.3.11.2. Russia: Market Size and Forecast, By Vector Type, 2023 – 2033 ($ Million)
10.3.11.3. Russia: Market Size and Forecast, By Application, 2023 – 2033 ($ Million)
10.3.12. REST OF EUROPE
10.3.12.1. Rest of Europe: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million)
10.3.12.2. Rest of Europe: Market Size and Forecast, By Vector Type, 2023 – 2033 ($ Million)
10.3.12.3. Rest of Europe: Market Size and Forecast, By Application, 2023 – 2033 ($ Million)
10.4. Asia Pacific
10.4.1. Asia Pacific: Market Size and Forecast, By Country, 2023 – 2033 ($ Million)
10.4.2. Asia Pacific: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million)
10.4.3. Asia Pacific: Market Size and Forecast, By Vector Type, 2023 – 2033 ($ Million)
10.4.4. Asia Pacific: Market Size and Forecast, By Application, 2023 – 2033 ($ Million)
10.4.5. CHINA
10.4.5.1. China: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million)
10.4.5.2. China: Market Size and Forecast, By Vector Type, 2023 – 2033 ($ Million)
10.4.5.3. China: Market Size and Forecast, By Application, 2023 – 2033 ($ Million)
10.4.6. JAPAN
10.4.6.1. Japan: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million)
10.4.6.2. Japan: Market Size and Forecast, By Vector Type, 2023 – 2033 ($ Million)
10.4.6.3. Japan: Market Size and Forecast, By Application, 2023 – 2033 ($ Million)
10.4.7. INDIA
10.4.7.1. India: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million)
10.4.7.2. India: Market Size and Forecast, By Vector Type, 2023 – 2033 ($ Million)
10.4.7.3. India: Market Size and Forecast, By Application, 2023 – 2033 ($ Million)
10.4.8. SOUTH KOREA
10.4.8.1. South Korea: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million)
10.4.8.2. South Korea: Market Size and Forecast, By Vector Type, 2023 – 2033 ($ Million)
10.4.8.3. South Korea: Market Size and Forecast, By Application, 2023 – 2033 ($ Million)
10.4.9. THAILAND
10.4.9.1. Thailand: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million)
10.4.9.2. Thailand: Market Size and Forecast, By Vector Type, 2023 – 2033 ($ Million)
10.4.9.3. Thailand: Market Size and Forecast, By Application, 2023 – 2033 ($ Million)
10.4.10. INDONESIA
10.4.10.1. Indonesia: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million)
10.4.10.2. Indonesia: Market Size and Forecast, By Vector Type, 2023 – 2033 ($ Million)
10.4.10.3. Indonesia: Market Size and Forecast, By Application, 2023 – 2033 ($ Million)
10.4.11. MALAYSIA
10.4.11.1. Malaysia: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million)
10.4.11.2. Malaysia: Market Size and Forecast, By Vector Type, 2023 – 2033 ($ Million)
10.4.11.3. Malaysia: Market Size and Forecast, By Application, 2023 – 2033 ($ Million)
10.4.12. AUSTRALIA
10.4.12.1. Australia: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million)
10.4.12.2. Australia: Market Size and Forecast, By Vector Type, 2023 – 2033 ($ Million)
10.4.12.3. Australia: Market Size and Forecast, By Application, 2023 – 2033 ($ Million)
10.4.13. REST FO ASIA PACIFIC
10.4.13.1. Rest fo Asia Pacific: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million)
10.4.13.2. Rest fo Asia Pacific: Market Size and Forecast, By Vector Type, 2023 – 2033 ($ Million)
10.4.13.3. Rest fo Asia Pacific: Market Size and Forecast, By Application, 2023 – 2033 ($ Million)
10.5. South America
10.5.1. South America: Market Size and Forecast, By Country, 2023 – 2033 ($ Million)
10.5.2. South America: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million)
10.5.3. South America: Market Size and Forecast, By Vector Type, 2023 – 2033 ($ Million)
10.5.4. South America: Market Size and Forecast, By Application, 2023 – 2033 ($ Million)
10.5.5. BRAZIL
10.5.5.1. Brazil: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million)
10.5.5.2. Brazil: Market Size and Forecast, By Vector Type, 2023 – 2033 ($ Million)
10.5.5.3. Brazil: Market Size and Forecast, By Application, 2023 – 2033 ($ Million)
10.5.6. ARGENTINA
10.5.6.1. Argentina: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million)
10.5.6.2. Argentina: Market Size and Forecast, By Vector Type, 2023 – 2033 ($ Million)
10.5.6.3. Argentina: Market Size and Forecast, By Application, 2023 – 2033 ($ Million)
10.5.7. REST OF SOUTH AMERICA
10.5.7.1. Rest of South America: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million)
10.5.7.2. Rest of South America: Market Size and Forecast, By Vector Type, 2023 – 2033 ($ Million)
10.5.7.3. Rest of South America: Market Size and Forecast, By Application, 2023 – 2033 ($ Million)
10.6. Middle East & Africa
10.6.1. Middle East & Africa: Market Size and Forecast, By Country, 2023 – 2033 ($ Million)
10.6.2. Middle East & Africa: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million)
10.6.3. Middle East & Africa: Market Size and Forecast, By Vector Type, 2023 – 2033 ($ Million)
10.6.4. Middle East & Africa: Market Size and Forecast, By Application, 2023 – 2033 ($ Million)
10.6.5. SAUDI ARABIA
10.6.5.1. Saudi Arabia: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million)
10.6.5.2. Saudi Arabia: Market Size and Forecast, By Vector Type, 2023 – 2033 ($ Million)
10.6.5.3. Saudi Arabia: Market Size and Forecast, By Application, 2023 – 2033 ($ Million)
10.6.6. UAE
10.6.6.1. UAE: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million)
10.6.6.2. UAE: Market Size and Forecast, By Vector Type, 2023 – 2033 ($ Million)
10.6.6.3. UAE: Market Size and Forecast, By Application, 2023 – 2033 ($ Million)
10.6.7. EGYPT
10.6.7.1. Egypt: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million)
10.6.7.2. Egypt: Market Size and Forecast, By Vector Type, 2023 – 2033 ($ Million)
10.6.7.3. Egypt: Market Size and Forecast, By Application, 2023 – 2033 ($ Million)
10.6.8. SOUTH AFRICA
10.6.8.1. South Africa: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million)
10.6.8.2. South Africa: Market Size and Forecast, By Vector Type, 2023 – 2033 ($ Million)
10.6.8.3. South Africa: Market Size and Forecast, By Application, 2023 – 2033 ($ Million)
10.6.9. REST OF MIDDLE EAST & AFRICA
10.6.9.1. Rest of Middle East & Africa: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million)
10.6.9.2. Rest of Middle East & Africa: Market Size and Forecast, By Vector Type, 2023 – 2033 ($ Million)
10.6.9.3. Rest of Middle East & Africa: Market Size and Forecast, By Application, 2023 – 2033 ($ Million)
CHAPTER 12. Competitive Landscape
12.1. Competitior Benchmarking 2023
12.2. Market Share Analysis
12.3. Key Developments Analysis By Top 5 Companies
12.4. Market Share Acquisition Strategies: Analysis of Key Approaches Employed by Top Players
CHAPTER 13. Company Profiles
13.1. REGENXBIO Inc
13.1.1. Business Overview
13.1.2. Financial Analysis
13.1.2.1. Business Segment Revenue, 2020, 2021, 2022, $ Million
13.1.2.2. Geographic Revenue Mix, 2022 (% Share)
13.1.3. Product Portfolio
13.1.4. Recent Development and Strategies Adopted
13.1.5. SWOT Analysis
13.2. Oxford BioMedica plc
13.3. Dimension Therapeutics Inc
13.4. Bristol-Myers Squibb Company
13.5. SANOFI
13.6. Applied Genetic Technologies Corporation.
13.7. Hoffmann-La Roche Ltd
13.8. bluebird Bio Inc
13.9. Novartis AG
13.10. Taxus Cardium Pharmaceuticals Group Inc

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us